These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 3311549

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
    Giordano M, Matsuda M, Sanders L, Canessa ML, DeFronzo RA.
    Diabetes; 1995 Jun; 44(6):665-71. PubMed ID: 7789631
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of calcium channel blockers and hydralazine on epinephrine-induced hyperglycemia in vivo.
    Ogihara M.
    Jpn J Pharmacol; 1989 Jun; 50(2):141-7. PubMed ID: 2770052
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nicardipine may impair glucose metabolism in hypertensive diabetic patients.
    Sasaki H, Naka K, Kishi Y, Ohoshi T, Hagihara T, Matsuo H, Sowa R, Matsumoto G, Sanke T, Nanjo K.
    Diabetes Res Clin Pract; 1994 Nov; 26(1):67-75. PubMed ID: 7533075
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nifedipine, a calcium-channel blocker, attenuated glucose intolerance and white adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
    Iwai M, Kanno H, Inaba S, Senba I, Sone H, Nakaoka H, Horiuchi M.
    Am J Hypertens; 2011 Feb; 24(2):169-74. PubMed ID: 20847723
    [Abstract] [Full Text] [Related]

  • 13. Diabetics with hypertension not controlled with ACE inhibitors: alternate therapies.
    Cleophas TJ, van Ouwerkerk BM, van der Meulen J, Zwinderman AH.
    Angiology; 2001 Jul; 52(7):469-75. PubMed ID: 11515986
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of calcium-blockers nicardipine, darodipine, PN-200-110 and nifedipine on insulin release from isolated rat pancreatic islets.
    Al-Mahmood HA, el-Khatim MS, Gumaa KA, Thulesius O.
    Acta Physiol Scand; 1986 Feb; 126(2):295-8. PubMed ID: 2939690
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Platelet aggregation and metabolic control are not affected by calcium antagonist treatment in type II diabetes mellitus.
    Klauser R, Speiser P, Gisinger C, Schernthaner G, Prager R.
    J Cardiovasc Pharmacol; 1990 Feb; 15 Suppl 1():S93-6. PubMed ID: 1695314
    [Abstract] [Full Text] [Related]

  • 19. Metabolic effects of enalapril and nifedipine in diabetic hypertensives.
    Andronico G, Angileri G, Piazza G, Cerasola G.
    J Hypertens Suppl; 1991 Dec; 9(6):S408-9. PubMed ID: 1819007
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.